Sintx Technologies, Inc. (SINT)
USD 2.5
(-3.47%)
USD 2.5
(-3.47%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -13.35 Million USD | -17.85% |
| 2022 | -11.33 Million USD | -6.73% |
| 2021 | -10.62 Million USD | -8.92% |
| 2020 | -9.75 Million USD | -47.86% |
| 2019 | -6.59 Million USD | 49.73% |
| 2018 | -13.11 Million USD | -18.66% |
| 2017 | -11.05 Million USD | 4.18% |
| 2016 | -11.53 Million USD | 4.2% |
| 2015 | -12.04 Million USD | 50.18% |
| 2014 | -24.16 Million USD | -133.84% |
| 2013 | -10.33 Million USD | 64.49% |
| 2012 | -29.1 Million USD | -39.54% |
| 2011 | -20.85 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.19 Million USD | -17.41% |
| 2024 Q2 | -2.71 Million USD | 15.23% |
| 2023 Q4 | -2.72 Million USD | 24.65% |
| 2023 FY | -13.35 Million USD | -17.85% |
| 2023 Q1 | -3.55 Million USD | -23.46% |
| 2023 Q2 | -3.46 Million USD | 2.61% |
| 2023 Q3 | -3.61 Million USD | -4.33% |
| 2022 Q1 | -2.88 Million USD | -11.15% |
| 2022 Q2 | -2.78 Million USD | 3.37% |
| 2022 Q3 | -2.79 Million USD | -0.36% |
| 2022 Q4 | -2.88 Million USD | -3.15% |
| 2022 FY | -11.33 Million USD | -6.73% |
| 2021 Q3 | -2.82 Million USD | -19.55% |
| 2021 Q1 | -2.84 Million USD | -26.94% |
| 2021 Q2 | -2.36 Million USD | 16.83% |
| 2021 FY | -10.62 Million USD | -8.92% |
| 2021 Q4 | -2.59 Million USD | 8.28% |
| 2020 FY | -9.75 Million USD | -47.86% |
| 2020 Q1 | -1.85 Million USD | -12.98% |
| 2020 Q2 | -1.98 Million USD | -7.01% |
| 2020 Q3 | -2.42 Million USD | -22.38% |
| 2020 Q4 | -2.23 Million USD | 7.83% |
| 2019 Q2 | -1.52 Million USD | 12.02% |
| 2019 Q4 | -1.64 Million USD | 3.47% |
| 2019 FY | -6.59 Million USD | 49.73% |
| 2019 Q1 | -1.73 Million USD | -6.99% |
| 2019 Q3 | -1.7 Million USD | -11.7% |
| 2018 Q1 | -2.14 Million USD | 56.88% |
| 2018 FY | -13.11 Million USD | -18.66% |
| 2018 Q3 | -7.36 Million USD | -262.27% |
| 2018 Q4 | -1.61 Million USD | 78.04% |
| 2018 Q2 | -2.03 Million USD | 5.18% |
| 2017 Q1 | -1.8 Million USD | 46.1% |
| 2017 FY | -11.05 Million USD | 4.18% |
| 2017 Q4 | -4.97 Million USD | -94.52% |
| 2017 Q3 | -2.55 Million USD | -48.26% |
| 2017 Q2 | -1.72 Million USD | 4.33% |
| 2016 Q1 | -2.48 Million USD | 5.66% |
| 2016 FY | -11.53 Million USD | 4.2% |
| 2016 Q4 | -3.34 Million USD | -4.24% |
| 2016 Q2 | -2.5 Million USD | -0.68% |
| 2016 Q3 | -3.2 Million USD | -28.23% |
| 2015 FY | -12.04 Million USD | 50.18% |
| 2015 Q4 | -2.63 Million USD | 6.17% |
| 2015 Q3 | -2.8 Million USD | -8.09% |
| 2015 Q2 | -2.59 Million USD | 35.2% |
| 2015 Q1 | -4 Million USD | -4.16% |
| 2014 Q1 | -4.05 Million USD | -41.34% |
| 2014 FY | -24.16 Million USD | -133.84% |
| 2014 Q4 | -3.84 Million USD | 31.77% |
| 2014 Q3 | -5.63 Million USD | 46.96% |
| 2014 Q2 | -10.62 Million USD | -162.03% |
| 2013 Q1 | -2.77 Million USD | 86.78% |
| 2013 Q3 | -2.01 Million USD | 24.53% |
| 2013 Q4 | -2.86 Million USD | -42.2% |
| 2013 Q2 | -2.67 Million USD | 3.57% |
| 2013 FY | -10.33 Million USD | 64.49% |
| 2012 Q3 | -2.06 Million USD | 0.0% |
| 2012 FY | -29.1 Million USD | -39.54% |
| 2012 Q4 | -20.97 Million USD | -913.61% |
| 2011 FY | -20.85 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 6.984% |
| Cerus Corporation | -30.05 Million USD | 55.552% |
| OrthoPediatrics Corp. | -25.76 Million USD | 48.156% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -25.766% |
| Talis Biomedical Corporation | -66.81 Million USD | 80.007% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 22.768% |
| Inogen, Inc. | -109.38 Million USD | 87.788% |
| Spectral AI, Inc. | -12.98 Million USD | -2.88% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 78.658% |
| CVRx, Inc. | -43.1 Million USD | 69.009% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -278.628% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -7.483% |
| Orthofix Medical Inc. | -139.11 Million USD | 90.398% |
| Venus Concept Inc. | -28.3 Million USD | 52.814% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 75.276% |
| Bioventus Inc. | -81.72 Million USD | 83.655% |
| BrainsWay Ltd. | -4.92 Million USD | -171.118% |
| Envoy Medical, Inc. | -18.37 Million USD | 27.288% |
| electroCore, Inc. | -18.8 Million USD | 28.966% |
| IceCure Medical Ltd | -15.57 Million USD | 14.24% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 72.448% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 22.643% |
| MaxCyte, Inc. | -48.29 Million USD | 72.343% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -11.733% |
| Nexalin Technology, Inc. | -5.69 Million USD | -134.503% |
| PAVmed Inc | -68.79 Million USD | 80.583% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 76.384% |
| RxSight, Inc. | -50.08 Million USD | 73.329% |
| Sight Sciences, Inc. | -57.27 Million USD | 76.677% |
| SI-BONE, Inc. | -46.93 Million USD | 71.537% |
| TELA Bio, Inc. | -44.07 Million USD | 69.693% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 75.331% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 74.026% |
| LivaNova PLC | -68.49 Million USD | 80.499% |
| 908 Devices Inc. | -42.75 Million USD | 68.759% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 92.296% |
| Nemaura Medical Inc. | -9.59 Million USD | -39.215% |
| NeuroPace, Inc. | -27.17 Million USD | 50.843% |
| LENSAR, Inc. | -12.22 Million USD | -9.232% |
| Apyx Medical Corporation | -17.25 Million USD | 22.603% |
| Cutera, Inc. | -156.23 Million USD | 91.45% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -55.253% |
| BioSig Technologies, Inc. | -28.51 Million USD | 53.15% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 84.758% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 40.488% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 111.977% |
| Axonics, Inc. | -26.05 Million USD | 48.735% |
| Outset Medical, Inc. | -169.77 Million USD | 92.132% |
| IRIDEX Corporation | -10 Million USD | -33.487% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 87.764% |
| IRadimed Corporation | 20.03 Million USD | 166.672% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -62.013% |
| INVO Bioscience, Inc. | -6.76 Million USD | -97.395% |
| Telesis Bio, Inc. | -35.15 Million USD | 61.997% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 193.217% |
| Varex Imaging Corporation | 32.1 Million USD | 141.614% |
| Quipt Home Medical Corp. | 3.91 Million USD | 440.852% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -10.096% |
| Pulmonx Corporation | -61.93 Million USD | 78.432% |
| Dynatronics Corporation | -2.27 Million USD | -487.669% |
| Modular Medical, Inc. | -17.52 Million USD | 23.795% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 8.751% |
| Semler Scientific, Inc. | 22.25 Million USD | 160.02% |
| InMode Ltd. | 195.66 Million USD | 106.827% |
| Bruker Corporation | 436.9 Million USD | 103.057% |
| Cytosorbents Corporation | -31.2 Million USD | 57.199% |
| DexCom, Inc. | 597.7 Million USD | 102.235% |
| Align Technology, Inc. | 643.33 Million USD | 102.076% |
| Viveve Medical, Inc. | -21.55 Million USD | 38.023% |
| ZimVie Inc. | -30.93 Million USD | 56.825% |
| Movano Inc. | -29.69 Million USD | 55.008% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 52.027% |
| Nexalin Technology, Inc. | -5.69 Million USD | -134.503% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -278.628% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 94.273% |
| Profound Medical Corp. | -28.61 Million USD | 53.32% |
| Insulet Corporation | 220 Million USD | 106.072% |
| enVVeno Medical Corporation | -25.23 Million USD | 47.072% |
| Surmodics, Inc. | -5.64 Million USD | -136.634% |
| iCAD, Inc. | -7.68 Million USD | -73.729% |
| Nuwellis, Inc. | -17.63 Million USD | 24.231% |
| Biotricity, Inc. | -8.82 Million USD | -51.309% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 89.327% |
| Aethlon Medical, Inc. | -12.63 Million USD | -5.709% |
| InspireMD, Inc. | -21.14 Million USD | 36.821% |
| PAVmed Inc. | -68.79 Million USD | 80.583% |
| BIOLASE, Inc. | -17.93 Million USD | 25.528% |
| Beyond Air, Inc. | -63 Million USD | 78.799% |
| FONAR Corporation | 16.53 Million USD | 180.784% |
| AxoGen, Inc. | -21.46 Million USD | 37.76% |
| Vivani Medical, Inc. | -26.96 Million USD | 50.462% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 174.042% |
| Inari Medical, Inc. | -14.03 Million USD | 4.803% |
| UFP Technologies, Inc. | 57.66 Million USD | 123.165% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -171.085% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -111.838% |
| Tenon Medical, Inc. | -15.72 Million USD | 15.063% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -78.726% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 68.721% |
| AdaptHealth Corp. | -598.4 Million USD | 97.768% |
| NanoVibronix, Inc. | -3.43 Million USD | -288.766% |
| Quanterix Corporation | -49.7 Million USD | 73.123% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -10.096% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -3396.859% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 96.006% |
| TransMedics Group, Inc. | -28.72 Million USD | 53.5% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 43.427% |
| NeuroMetrix, Inc. | -7.15 Million USD | -86.785% |
| Hyperfine, Inc. | -48.11 Million USD | 72.237% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 79.457% |
| Biomerica, Inc. | -6.36 Million USD | -109.801% |
| Bone Biologics Corporation | -9.42 Million USD | -41.68% |
| AVITA Medical, Inc. | -40.4 Million USD | 66.937% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -29.548% |
| Silk Road Medical, Inc | -59.27 Million USD | 77.463% |